InvestorsHub Logo

XenaLives

02/06/17 9:35 AM

#90050 RE: nobrainerstocks #90049

The ability to follow that program is by definition selection bias.

Antti

02/06/17 9:38 AM

#90051 RE: nobrainerstocks #90049

The point was actually just to show that multiple treatment protocols can have quite dramatic results when you just look at some case studies.

For example one competitor has a case study available where patient improved from MMSE score 0-2 to 12. Quite remarkable improvement don't you think. But it was still just one patient just like Anavex has some.